Machine Learning for Lymph Node Metastasis Prediction in Early Gastric Cancer: A Comparative Analysis
Yufan Chen1, Kunhao Bai1, Minghui Yang1
1Department of Endoscopy, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong, China.
International Journal of Medical Sciences
|March 9, 2026
Summary
Machine learning models can predict lymph node metastasis (LNM) in early gastric cancer (EGC). This study identified key risk factors, aiding personalized treatment decisions for EGC patients with LNM.
Area of Science:
- Oncology
- Medical Informatics
- Surgical Oncology
Background:
- Lymph node metastasis (LNM) is critical for staging and treatment of early gastric cancer (EGC).
- Accurate prediction of LNM is essential for guiding surgical and adjuvant therapy decisions in EGC.
- Current methods for LNM prediction in EGC may benefit from advanced analytical approaches.
Purpose of the Study:
- To develop and evaluate machine learning algorithms for predicting lymph node metastasis (LNM) in early gastric cancer (EGC).
- To identify key predictors of LNM in EGC patients to inform clinical decision-making.
- To compare the performance of various machine learning models in predicting LNM in EGC.
Main Methods:
- Data from 1085 EGC patients undergoing gastrectomy with lymph node resection were analyzed.
- Seven machine learning algorithms were trained and validated, with hyperparameter tuning.
- Model performance was assessed using accuracy, Brier class, and Area Under the Curve (AUC).
Main Results:
- Random Forest, Extreme Gradient Boosting, and Neural Network models showed strong performance on the validation set (AUCs 0.796, 0.788, 0.779).
- Subgroup analyses in T1a and T1b stages revealed varying model performances (e.g., Logistics Models and RF for T1a).
- SHAP analysis identified distinct variable importance for LNM prediction in EGC and its subgroups.
Conclusions:
- Machine learning models demonstrate potential for predicting LNM in EGC, enhancing treatment strategy development.
- Identified risk factors provide valuable insights for personalized management of EGC patients.
- These predictive models can support clinical decision-making for EGC with LNM.


